Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease

被引:172
|
作者
Chang, Yoosoo
Ryu, Seungho
Sung, Eunju
Jang, Yumi
机构
[1] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Hlth Screening Ctr, Seoul 110746, South Korea
[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat Med, Seoul 110746, South Korea
[3] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul 110746, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Ulsan, South Korea
关键词
D O I
10.1373/clinchem.2006.081257
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: In nonalcoholic fatty liver disease (NAFLD), increased alanine aminotransferase (ALT) concentrations are considered to be a consequence of hepatocyte damage. We performed a prospective study to examine the association between ALT within its reference interval and risk for subsequent development of NAFLD. Methods: The study cohort comprised 5237 healthy men without diagnosed NAFLD and without increases of either ALT (>= 35 U/L) or gamma-glutamyltransferase (GGT; >= 40 U/L) above the reference intervals. We assessed alcohol intake via self-reporting (questionnaire) and performed biochemical tests for liver and metabolic function and abdominal ultrasonography. We used the Cox proportional hazards model to calculate the adjusted hazard ratios (aHRs) in the model for NAFLD. Results: During 13 276.6 person-years of follow-up over a 4-year period, 984 new incident cases of NAFLD developed. We adjusted for age, weight change, body mass index, glucose, blood pressure, triglycerides, HDL cholesterol, smoking, alcohol consumption, regular exercise, homeostasis model assessment of insulin resistance, C-reactive protein, and incident diabetes. Compared with an ALT concentration of < 16 U/L, aHR values (95% confidence intervals) for ALT concentrations were 1.53 (1.18-1.98), 1.66 (1.29-2.13), 1.62 (1.26-2.08), and 2.21 (1.73-2.81) for ALT concentrations of 16-18, 19-21, 22-25, and 26-34 U/L, respectively. This relationship remained significant even among normal-weight participants who were still within the reference interval of ALT and GGT at all follow-up examinations. Conclusions: In apparently healthy, nondiabetic Korean men, increased ALT concentration, even within the reference interval, was an independent predictor of incident NAFLD. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:686 / 692
页数:7
相关论文
共 50 条
  • [21] There's More under the Nonalcoholic Fatty Liver Disease Umbrella Than an Elevated Alanine Aminotransferase Level
    Kohli, Rohit
    JOURNAL OF PEDIATRICS, 2014, 164 (04): : 684 - 686
  • [22] Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels
    Molleston, Jean P.
    Schwimmer, Jeffrey B.
    Yates, Katherine P.
    Murray, Karen F.
    Cummings, Oscar W.
    Lavine, Joel E.
    Brunt, Elizabeth M.
    Scheimann, Ann O.
    Unalp-Arida, Aynur
    JOURNAL OF PEDIATRICS, 2014, 164 (04): : 707 - U54
  • [23] Effect of illness uncertainty on alanine transaminase levels and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease
    Ozawa, Naoki
    Sato, Kazuki
    Sugimura, Ayumi
    Maki, Shigeyoshi
    Tanaka, Taku
    Yamamoto, Kenta
    Ito, Takanori
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    Ishikawa, Tetsuya
    Ando, Shoko
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (04) : 857 - 864
  • [24] Alanine Aminotransferase (ALT) to Triglyceride (TG) Ratio As a Marker of Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Children
    Mani, Shrinidi
    Eng, Katharine
    Lopez, Rocio
    Moses, Jonathan
    Alkhouri, Naim
    GASTROENTEROLOGY, 2013, 144 (05) : S1011 - S1011
  • [25] Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
    Miyake, Teruki
    Matsuura, Bunzo
    Furukawa, Shinya
    Yoshida, Osamu
    Hirooka, Masashi
    Kumagi, Teru
    Ishihara, Toru
    Kanzaki, Sayaka
    Nakaguchi, Hironobu
    Miyazaki, Masumi
    Nakamura, Yoshiko
    Yamamoto, Yasunori
    Koizumi, Yohei
    Tokumoto, Yoshio
    Takeshita, Eiji
    Ikeda, Yoshio
    Abe, Masanori
    Kitai, Kohichiro
    Hiasa, Yoichi
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (10) : 1890 - 1898
  • [26] SERUM ALANINE AMINOTRANSFERASE AS PREDICTOR OF INTERVENTRICULAR SEPTUM THICKNESS AND LEFT VENTRICULAR MASS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Ballesta, C.
    Serradilla, M.
    Gonzalez, C.
    OBESITY SURGERY, 2014, 24 (08) : 1168 - 1168
  • [27] Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease
    Ybarra, Juan
    Fernandez, Sandra
    Sanchez-Hernandez, Joan
    Romeo, June H.
    Ballesta-Lopez, Carlos
    Guell, Javier
    Mearin, Fermin
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (06) : 654 - 660
  • [28] Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data
    Arsik, Idil
    Frediani, Jennifer K.
    Frezza, Damon
    Chen, Wen
    Ayer, Turgay
    Keskinocak, Pinar
    Jin, Ran
    Konomi, Juna V.
    Barlow, Sarah E.
    Xanthakos, Stavra A.
    Lavine, Joel E.
    Vos, Miriam B.
    CHILDREN-BASEL, 2018, 5 (06):
  • [29] The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels
    Kim, Kyung-Soo
    Oh, Hyun-Ju
    Kim, Dae-Jung
    Kim, Soo-Kyung
    Park, Seok Won
    Cho, Yong-Wook
    Huh, Kap-Bum
    ENDOCRINE JOURNAL, 2013, 60 (12) : 1295 - 1301
  • [30] Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hyperglycemia
    Su, Ching-Chieh
    Wang, Kun
    Hsia, Te-Lin
    Chen, Ching-Shuen
    Tung, Tao-Hsin
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (06) : 551 - 554